Entries |
Document | Title | Date |
20080206311 | Sucrase Activity Inhibitor, Glucoamylase Activity Inhibitor and Food and Feed Containing the Same - The invention provides a sucrose activity inhibitor and a glucoamylase activity inhibitor comprising one or more saccharides selected from the group consisting of palatinose, trehalulose and palatinit. Further, the invention provides a food or feed comprising the sucrose activity inhibitor and/or the glucoamylase activity inhibitor. | 08-28-2008 |
20080206312 | Therapeutic Morpholino-Substituted Compounds - Morpholino-substituted pyridopyrimidine, quinolone, and benzopyranone derivatives inhibit phosphoinositide (PI) 3-kinase, an enzyme that regulates platelet-adhesion processes. As a consequence, the compounds in question have anti-thrombotic activity, as well as other pharmaceutical properties. The compounds claimed are represented by formula (I), (II) and (III). PI 3-kinase generates 3-phosphorylated PI second messengers which stimulate platelet adhesion under blood-flow conditions. Because platelet adhesion is a necessary step in the formation of a thrombus, inhibition by these compounds of PI 3-kinase under such conditions inhibits or prevents thrombus formation. The compounds are useful in treating PI 3-kinase-dependent conditions including cardiovascular diseases such as coronary artery occlusion, stroke, acute coronary syndrome, acute myocardial infarction, vascular restenosis, atherosclerosis, and unstable angina; respiratory diseases such as asthma, chronic obstructive pulmonary diseases (COPD), and bronchitis; inflammatory disorders; neoplasms including cancers such as glioma, prostate cancer, small cell lung cancer, and breast cancer; and diseases linked to disordered white blood cell function, such as autoimmune and inflammatory diseases. | 08-28-2008 |
20080206313 | COMPOSITIONS USEFUL ESPECIALLY FOR TREATMENT OR PREVENTION OF METABOLIC SYNDROME - This invention relates to a method for treatment or prevention of metabolic syndrome and diseases or conditions resulting therefrom in an individual, wherein an effective amount of an amine oxidase enzyme inhibitor is administered to said individual. In addition, the invention relates to a method for inhibiting an amine oxidase enzyme or for treatment or prevention of diseases or conditions benefiting from inhibition of an amine oxidase enzyme in an individual, wherein a vitamin B1, its derivative, its precursor or metabolite is administered to said individual. Finally, the invention relates to a food product comprising an amine oxidase enzyme inhibitor in combination with a foodstuff, a food additive comprising an amine oxidase enzyme inhibitor in combination with a liquid, solid or semisolid carrier. | 08-28-2008 |
20080213340 | Transformed Plant Cell Expressing Tandem Repeats of Beta-Amyloid Gene and Plant Produced by the Same - The present invention relates to a transformed plant cell expressing β-amyloid gene, which is known as a causal substance of senile dementia in human, a transformed plant and a preparation method of the same, more particularly, to a transformed plant cell expressing tandem repeats of β-amyloid gene, a transformed plant produced by tissue-culturing the above cells and a preparation method of the same. The transformed plant of the present invention expresses multiple β-amyloid protein, so that the plant can be effectively used for the preparation of an oral vaccine composition for the prevention of senile dementia in human. | 09-04-2008 |
20080213341 | Butyric Acid Esters of Carbohydrates and Carbohydrate Polyols - The invention relates to butyric acid esters or butyrate esters of carbohydrates and carbohydrate polyols and their use as a butyrate carrier and butyrate source for the gastrointestinal tract, in particular for the prevention and treatment of diseases of the gastrointestinal tract, especially of the large intestine. | 09-04-2008 |
20080220051 | Powdery Sterol Compositions Containing Colloid-Forming Agents - Compositions in powder form of sterols, stanols, and esters thereof, and natural macromolecular colloid formers are disclosed. A process of making the compositions is also disclosed. The suitability of incorporation of the compositions in powder form in food products, for example beverages and milk products, is also disclosed. | 09-11-2008 |
20080220052 | Body weight gain inhibitor - The invention provides a body weight gain inhibitor, a fat amount gain inhibitor, a medicament for prevention and/or treatment of obesity, a food composition having inhibitory effect on body weight gain and a food composition having inhibitory effect on fat amount gain, each containing ε-polylysine or a salt thereof. In another aspect of the invention, the described compositions are useful for inhibiting body weight gain, inhibiting fat amount gain and preventing and/or treating obesity. | 09-11-2008 |
20080226695 | THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM - The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. | 09-18-2008 |
20080233175 | Glucanases, Nucleic Acids Encoding Them And Methods For Making And Using Them - The invention relates to polypeptides having glucanase, e.g., endoglucanase, mannanase, xylanase activity or a combination of these activities, and polynucleotides encoding them. In one aspect, the glucanase activity is an endoglucanase activity (e.g., endo-1,4-beta-D-glucan 4-glucano hydrolase activity) and comprises hydrolysis of 1,4-beta-D-glycosidic linkages in cellulose, cellulose derivatives (e.g., carboxy methyl cellulose and hydroxy ethyl cellulose) lichenin, beta-1,4 bonds in mixed beta-1,3 glucans, such as cereal beta-D-glucans or xyloglucans and other plant material containing cellulosic parts. In addition, methods of designing new enzymes and methods of use thereof are also provided. In alternative aspects, the new glucanases e.g., endoglucanases, mannanases, xylanases have increased activity and stability at increased pH and temperature. | 09-25-2008 |
20080241226 | Methods and Kits For Administering Probiotics - Methods for administering probiotics comprising the steps of: administering a loading dose of a loading probiotic for a loading time period; and administering a dose of a botanical and/or additional materials for the loading time period are disclosed. The methods also include administering a maintenance dose of a maintenance probiotic, and/or a botanical and/or an additional material for a maintenance time period. Also disclosed are kits for use in administering probiotics. | 10-02-2008 |
20080248088 | Decontaminant edible product, methods of production and uses thereof - The invention relates to an edible product containing a decontaminant. Particularly, the invention relates to an edible product, for instance, a food-like product, containing an effective amount of activated charcoal to mitigate, substantially reduce or cause the cessation of at least one adverse effect associated with the ingestion of a toxic substance. The invention also relates to methods for manufacturing such a decontaminant edible product and uses thereof. | 10-09-2008 |
20080254099 | Pharmaceutical Compositions Comprising Polymeric Binders with Non-Hydrolysable Covalent Bonds and Their Use in Treating Celiac Disease - A pharmaceutical composition comprising a polymeric binder including a high molecular weight synthetic polymer having a backbone constituted of non hydrolysable covalent bonds, said polymer being able to form electrostatic bonds at a pH lower than the isoelectric point of gluten and peptides derived from the degradation of gluten, and being able to bind to gluten or peptides derived from the degradation of gluten in the gastrointestinal tract, and a pharmaceutically acceptable carrier. Methods of using the polymeric binder for binding gluten or a peptide derived from the degradation of gluten, for decreasing the degradation of gluten into toxic peptides or for decreasing interaction of gluten or peptides derived from the degradation of gluten with the gastrointestinal mucosa. | 10-16-2008 |
20080254100 | METHODS OF USING GAMMA CYCLODEXTRIN TO CONTROL BLOOD GLUCOSE AND INSULIN SECRETION - Disclosed are methods of producing a blunted postprandial glycemic response in an individual, and/or reducing postprandial insulin secretion, said methods comprising administering to the individual a nutritional or other product comprising gamma-cyclodextrin. Also disclosed are similar other methods directed toward the use of such products to provide weight and appetite control, to normalize blood glucose levels in individuals with impaired glucose tolerance, to minimize nighttime hypoglycemia in diabetic and non-diabetic patients, to prevent reactive hypoglycemia in susceptible non-diabetics, to normalize blood glucose levels in individuals with gestational diabetes or impaired glucose tolerance during gestation, and/or to provide a prolonged glycemic response during exercise. The methods are based upon the discovery that gamma-cyclodextrins are rapidly metabolized and absorbed in the small intestine, but subsequently result in a surprisingly blunted postprandial glycemic response and reduced insulin secretion. | 10-16-2008 |
20080260805 | THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM - The invention relates to film products containing desired levels of active components and methods of their preparation. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films may be exposed to temperatures above that at which the active components typically degrade without concern for loss of the desired activity. | 10-23-2008 |
20080268024 | Compositions for Oral and/or Topical Administration - Compositions for oral and/or topical administration of a prebiotic and a polyphenol or a plant extract containing a polyphenol, and mixtures thereof, are disclosed. The compositions are disclosed as enhancing the body's population of beneficial microorganisms for improving health and well-being. | 10-30-2008 |
20080268025 | Compositions Useful for Preventing Pain and Soreness Resulting from Exercise and Methods of Use - Provided are beverages containing one or more anti-inflammatory agents, derivatives thereof, prodrugs thereof, salts thereof, or combinations thereof. Additional components include, but are not limited to, electrolytes, minerals, vitamins, flavorings, antacids, buffers, dissolution enhancers and solubility enhancers. Additionally, a beverage mix containing an anti-inflammatory agent is disclosed. Furthermore, a method for preventing or mitigating pain or soreness is disclosed. | 10-30-2008 |
20080268026 | Food-induced antisecretory proteins - The use of products having enzymatic activity for the preparation of a food, including feed, inducing, when consumed, antisecretory proteins and the foods thus prepared. The products having enzymatic activity may for example be malted cereals. | 10-30-2008 |
20080268027 | THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM - The invention relates to the film products and methods of their preparation that demonstrate a non-self-aggregating uniform heterogeneity. Desirably the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. | 10-30-2008 |
20080292681 | Use of Dha, Epa or Dha-Derived Epa for Treating a Pathology Associated with Cellular Oxidative Damage - The present invention relates to the use of an acid enriched in docosahexaenoic acid (DHA) or eicosapentaenoic acid (EPA) or DHA-derived EPA for manufacturing a drug for the treatment of processes that involve associated oxidative damage. In particular, it is for the treatment of processes associated with neurodegenerative, ocular, ischaemic and inflammatory pathology, atherosclerosis, with oxidative damage to DNA and with physical exercise. | 11-27-2008 |
20080299180 | Peptides based on the sequence of human lactoferrin and their use - The invention relates to new peptides formed of at least seven subsequent amino acids of the amino acids in position 12-40, counted from the N-terminal end, in the sequence constituting human lactoferrin, and preferably modifications thereof. The invention also relates to medicinal products comprising such peptides, especially intended for treatment and prevention of infections, inflammations and tumours. Furthermore, the invention relates to food stuff, e.g. infant formula food, comprising the above mentioned peptides. | 12-04-2008 |
20080299181 | ODOURLESS GARLIC SUPPLEMENT COMPRISING AN ENTERIC COATING AND A DEODORISING LAYER - A garlic supplement comprises one or more cores comprising garlic and an enteric coating encasing the core(s) which is insoluble at pH less than about 5 but soluble at a pH greater than about 5. In one example, the enteric coating comprises a deodorizer. In another example, an external coating is present over the enteric coating and the external coating includes a deodorizer. | 12-04-2008 |
20080305150 | Polymer Composition And Dosage Forms Comprising The Same - A composition comprising a high molecular weight, water soluble polymer having a cloud point from about 20 to about 90° C. and a gelling polymer is provided. The composition may be used as a component of a pharmaceutical dosage form, such as the shell of a dosage form, or as an edible matrix, i.e., a pharmaceutical dosage form per se. | 12-11-2008 |
20080305151 | Dipeptide-Comprising Composition for Oral Administration - The present invention provides a composition for oral administration, which comprises at least one kind of dipeptide represented by the formula: | 12-11-2008 |
20080311174 | Food and Process for Producing Food - The present invention retains the original shape, color, taste, flavor and texture, suppresses liquating out nutritional contents, can easily adjust the hardness of a food, can efficiently manufacture a processed food which uses a wide variety of food materials, can preserve by suppressing microbial deterioration due to its hygienic manufacture, and can easily and manufacture a processed food in a short period of time, wherein the food is capable of supplying nutritious substance according to need. The method of manufacturing a food of the present invention including bringing either one or both of a thickener in a non-solvated state and microorganism which generates a viscous material into contact with the surface of a food material, and performing a pressure treatment, such that the food retains the shape of the food material and uniformly includes either one or both of a thickener in a non-solvated state and microorganism which generates a viscous material inside. | 12-18-2008 |
20080317821 | Lipase Inhibitors - The present invention provides lipase inhibitors containing dimers of flavan-3-ols derived from teas as well as foods and beverages and medicines containing said inhibitors. More specifically, the present invention provides lipase inhibitors containing at least one of assamicains represented by the formula: | 12-25-2008 |
20080317822 | Methods for Delivery of Nanosome Encapsulated Agents - Vitamins, minerals, antioxidants, and growth factors are encapsulated in nanosomes and the nanosomes suspended in beverages. The nanosomes effectively cross the through the stomach and into the blood stream to be delivered to cells while protecting the contents encapsulated in the cell from degradation prior to delivery to the final target. | 12-25-2008 |
20080317823 | High Pressure Processing of Bioactive Compositions - The present invention relates to a method of pressure treating a bioactive composition comprising at least one bioactive component to prevent the growth of at least one unwanted microorganism while retaining a desired level activity of the at least one bioactive component. The bioactive component is selected from one or more proteins protein hydrolysates, one or more lipids or lipid hydrolysates, one or more carbohydrates, one or more probiotic factors, or mixtures thereof. The pressure treatment is at a predetermined pressure from about 350 to 1000 MPa. | 12-25-2008 |
20080317824 | Chocolate Coated Spherical Filled Capsules - Described is a spherical coated capsule comprising a coating-free capsule having (i) a liquid or viscous core ( | 12-25-2008 |
20090004247 | Novel substance derived from basidiomycetes culture, method for producing it and its use - A novel substance that has the physiological activity of the aglycone of isoflavones and the physiological activity of the culture of the basidiomycetes with the physiological activities being synergistically enhanced, obtained by cultivating a basidiomycetes having a β-glucosidase activity in a medium containing an isoflavone, a method for producing it, and food, feedstuff and medicine containing it. | 01-01-2009 |
20090010992 | Drug formulations for oral transmucosal delivery to pediatric patients - Improved compositions, methods and systems for oral transmucosal administration of small volume bioadhesive drug dosage forms to pediatric subjects are provided. The drug dosage form is easily administered and may be delivered using a single dose applicator or a device. | 01-08-2009 |
20090010993 | Composition comprising polyphenol - A food product, being a spread comprising from 10-85 wt % of fat or a dairy based drink comprising from 0.05 to 1 wt % of kaempferol can advantageously be used to control blood pressure. Specifically kaempferol may be used for vasorelaxation. | 01-08-2009 |
20090017099 | CHOLESTEROL-RICH COMPOSITE FOOD THAT IS RENDERED SUBSTANTIALLY NON-CHOLESTEROLEMIC USING PHYTOSTEROLS - A composite food is described that includes a single serving portion of a cholesterol-rich food component (abbreviated CRFC) such as a hamburger or hot dog, and a cholesterol-compensating flour-based baked bun configured and sized to hold the CRFC. The bun contains a sufficient amount of phytosterols to compensate for the cholesterol contained in the CRFC, and the phytosterols are provided in a physical and chemical form that is bioavailable during digestion of the composite food. | 01-15-2009 |
20090017100 | PHARMACEUTICAL COMPOSITION, FOOD OR DRINK, OR FEED FOR INTESTINAL DISEASE - It is intended to provide a pharmaceutical composition, a food or drink, or a feed which has an effect on the prevention and/or treatment of an intestinal disease such as ulcerative colitis, Crohn's disease or irritable bowel syndrome. A preferred embodiment is the pharmaceutical composition, food or drink, or feed which contains lactoperoxidase as an active ingredient and has an effect on the prevention and/or treatment of an intestinal disease, wherein the intestinal disease is at least one disease selected from ulcerative colitis, Crohn's disease and irritable bowel syndrome. | 01-15-2009 |
20090092657 | Amino acid combinant omega oil aphrodisiac - A method of enhancing the libido in an adult human comprising the administering of a composition, comprising an effective amount of the amino acids tryptophan and phenylalanine and an effective amount of omega oils. | 04-09-2009 |
20090104251 | HEAT STABLE MICROCAPSULES AND METHODS FOR MAKING AND USING THE SAME - A method of manufacturing a microcapsule that may include complex coacervating a protein and a polyanionic polymer to form a coacervate, the coacervate being at least a portion of the microcapsule, and wherein a cross-linking reagent is not used during the coacervation. | 04-23-2009 |
20090110715 | Edible film Package Having Product for Oral Intake Enclosed Therein - This invention aims to provide a novel taking or having-or-swallowing form for an oral material, such as drugs or foodstuffs. | 04-30-2009 |
20090123523 | PHARMACEUTICAL DELIVERY SYSTEM - The present invention is directed to methods and compositions for administering medicaments to large animals by enveloping a medicament within a food stuff. | 05-14-2009 |
20090123524 | PACKAGED SATIETY ENHANCING COMPOSITION - Compositions for enhancing satiety and weight loss in an individual, assays for assessing a tastant for enhancing satiety and weight loss, and methods of using the composition to suppress appetite and enhance weight loss are provided. | 05-14-2009 |
20090148501 | PROCESS FOR THE PREPARATION OF AROMATIZED CHEWING FOAMS FOR COSMETIC PRODUCTS - The invention relates to a process for the preparation of novel aromatized chewing foams for the oral care sector based on polyurethane-polyureas and aromatizing compositions | 06-11-2009 |
20090196907 | EDIBLE FILM-STRIPS FOR IMMEDIATE RELEASE OF ACTIVE INGREDIENTS - The present invention is directed to an edible film that contains two or more segmented portions and comprises an active ingredient that is distributed on a segmented portion or portions which comprise less than 50% of the cross sectional surface area of a major face of said film. The present invention also relates to methods of treatment for the treatment of various conditions and for taste-masking of pharmaceutical ingredients. | 08-06-2009 |
20090202613 | Nutritionally Enhanced Therapeutic Preventative Food Supplement and Method of Making Same - The present invention is directed to a nutritionally enhanced therapeutic preventative food supplement which includes one or more food ingredients, a mineral and vitamin mix component, a base coating component, and an immune system potentiate, wherein the immune system potentiate is not denatured. The present invention includes a process to make an enhanced therapeutic food supplement and a method to potentiate the immune system of a mammal in need thereof. | 08-13-2009 |
20090214620 | AGENT FOR USE IN THE CASE OF DISORDERS OF BLOOD SUGAR METABOLISM, INCLUDING DIABETES - An agent for use in the case of disorders of blood sugar metabolism, including diabetes, is described, which reduces the glucose content of food and other substances with the help of 5-D-fructose dehydrogenase and glucose isomerase. | 08-27-2009 |
20090220575 | COMPOSITIONS AND METHODS FOR THE SUSTAINED RELEASE OF BETA-ALANINE - Methods and compositions are provided for increasing the anaerobic working capacity of muscle and other tissues. Also provided are compositions formulated for the sustained release of free beta-alanine. | 09-03-2009 |
20090220576 | EMULSION - The invention relates to an orally administrable chewable composition in unit dosage form comprising an oil-in-water emulsion in which the aqueous phase is gelled and in which the oil phase comprises a physiologically tolerable unsaturated fatty acid ester. | 09-03-2009 |
20090232872 | METHOD AND APPARATUS FOR MINIMIZING HEAT, MOISTURE, AND SHEAR DAMAGE TO MEDICANTS AND OTHER COMPOSITIONS DURING INCORPORATION OF SAME WITH EDIBLE FILMS - A medicant composition is provided. The composition includes a film layer and a powder matrix layer. The powder matrix layer includes a medicant. The powder matrix layer is applied to the film layer by admixing particulate to form a powder matrix and by then applying the powder matrix to the film layer by any desired method. The composition of the powder matrix is varied to alter the dissolution rate of the medicant, the adhesion of the medicant composition, and other physical properties of the powder matrix. The powder matrix layer can be cured. | 09-17-2009 |
20090263466 | HERBAL COMPOSITION FOR TREATMENT OF HYPERLIPIDEMIA AND THE INHIBITION OF MYOCARDIAL INFARCTION - A pharmaceutical or medicinal herbal composition and method of making the composition comprised of a mixture of the following herbal ingredients: | 10-22-2009 |
20090280159 | PROCESS FOR MANUFACTURING CHEWABLE DOSAGE FORMS FOR DRUG DELIVERY AND PRODUCTS THEREOF - A palatable, soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the soft chews do not require the generation of heat during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture. | 11-12-2009 |
20090291121 | CAPSULE AND COATED CAPSULES AS A DELIVERY SYSTEM FOR DIETARY SUPPLEMENTS AND THERAPEUTIC MATERIALS - A coated spherical capsule that comprises a seamless capsule and an edible coating is disclosed. The seamless capsule includes a seamless solid shell surrounding a mononuclear liquid or viscous core and the edible coating surrounding the seamless capsule. The edible coating can include at least one dietary supplement and at least one sugar or sugar alcohol. The liquid or viscous core can include 1-100% of a flavoring, based on total weight of the liquid or viscous core. The edible coating can include an effective amount of the at least one dietary supplement based on the weight of the edible coating. Also disclosed is a method of administering an effective amount of a dietary supplement. The method includes providing a plurality of coated spherical capsule and ingesting at least one coated spherical capsule for two or more days in order to deliver an effective amount of a dietary supplement. | 11-26-2009 |
20100021525 | Method for Producing Sterol Formulations - The invention relates to a method for producing coated sterol powders. According to said method, a) micronized sterol and/or stanol particles are provided in a mixer, b) the micronized sterol and/or stanol particles are wetted with a proteinaceous aqueous solution/dispersion, c) the wetted particles are mixed well and then dried, and d) the dried mixture is optionally size-reduced in a mill. Owing to their good wettability, the sterol-containing formulations produced according to this method can be incorporated into food items without technical complications and have good organoleptic and sensory properties especially when used in drinks and dairy products. | 01-28-2010 |
20100047320 | ORAL POLYMERIC MEMBRANE FERULOYL ESTERASE PRODUCING BACTERIA FORMULATION - The present invention relates to an oral formulation to lower serum or hepatic lipid and triglyceride concentrations, hepatic inflammation and/or insulin resistance in a patient comprising live feruloyl esterase producing microorganisms alone or in association with a pharmaceutically acceptable carrier resistant to gastric conditions, and wherein the microorganisms are wild type, genetically modified, or combination thereof. The present invention is also directed to an oral formulation to lower serum or hepatic lipid and triglyceride concentrations, hepatic inflammation and/or insulin resistance in a patient, which comprises polymeric microcapsules containing live feruloyl esterase producing microorganisms in suspension in a pharmaceutically acceptable carrier, wherein said microcapsules are semipermeable and resistant to gastro-intestinal conditions, and wherein said microorganism are wild type, genetically modified, or combination thereof as well as methods of preventing or improving liver diseases and disorders and uses thereof. | 02-25-2010 |
20100062040 | WATER SOLUBLE DRUGS AND SUPPLEMENTS - A method of forming water soluble microparticles is disclosed that includes the steps of providing a water insoluble food supplement, mixing the food supplement in a water miscible polar solvent, heating the mixture to increase the solubility and dissolve the food supplement into the solvent to form a saturated solution, and streaming the solution into water to form a solvent-water mix such that microparticles of the food supplement are produced | 03-11-2010 |
20100112035 | MULTIPLE COMPONENT FOOD PRODUCT USEFUL FOR DELIVERING GLUCOSAMINE AND/OR N-ACETYL-D-GLUCOSAMINE - Food products containing at least two components are provided. These products have at least one baked component and at least one non-baked component. The non-baked component contains either GLCN and/or NAG. | 05-06-2010 |
20100150986 | FILM PREPARATION WITH RAPIDLY DISSOLVING PROPERTY AND FLEXIBILITY - The present invention relates to a film preparation having both rapid solubility and flexibility at the same time. The film preparation is characterized by comprising: an active-ingredient-containing layer comprising an active ingredient, a water-soluble polymer selected from the group consisting of methyl cellulose, hydroxypropyl cellulose, and hydroxypropyl methyl cellulose, and a disintegrating agent; and an active-ingredient-free layer comprising methyl cellulose and/or hydroxypropyl methyl cellulose. It is further characterized in that the amount of the active ingredient is 0.1-75.0 mass % of a total mass of the film preparation and a total content of the active ingredient and the water-soluble polymer in the active-ingredient-containing layer is 15.0-95.0 mass % of a total mass of the active-ingredient-containing layer. | 06-17-2010 |
20100158984 | Encapsulates - An encapsulate comprises an outer shell and an inner core, the inner core comprising an ingredient selected from plant sterol compounds such as phytosterols and/or phytostanols and/or their esters, and at least one, preferably at least two, of the following groups: a, b, c, d, e, f, g, h, i, j, k.
| 06-24-2010 |
20100189767 | PROBIOTIC COMPOSITIONS AND METHODS OF MAKING SAME - The present invention provides solid compositions of bioactive agents, in particular of probiotic microorganisms. Furthermore, the present invention provides methods for preparing these compositions. The methods include microencapsulating live microorganisms to produce a dry formulation and optionally coating the microcapsules while retaining to a significant extent the viability of the microorganisms. | 07-29-2010 |
20100196443 | USE OF CORDYCEPS SPECIES OR EXTRACT THEREOF IN THE EGG PRODUCTION - A dietary supplement or animal feed includes at least one | 08-05-2010 |
20100233243 | Laminated Microcapsule Sheet and Process For Production Thereof - Disclosed is a laminated microcapsule sheet which is produced using a lamination apparatus B and a water repellency imparting apparatus A, wherein the lamination apparatus B is used for laminating multiple types of materials at multiple parts on an edible film to form a laminated microcapsule sheet and the water repellency imparting apparatus A is used for imparting water repellency to the surface of the edible sheet. The sheet is improved in the disadvantages attributable to the water soluble property of an edible film. | 09-16-2010 |
20100239638 | CHEWABLE SOFT CAPSULE HAVING IMPROVED INGESTION PROPERTY AND METHOD FOR PRODUCING SAME - A soft capsule in which a shell is filled with fill material, and the fill material is in a solid or semi-solid form at room temperature. The soft capsule may be a chewable capsule, and the fill material may comprise a low melting point additive. The content of the low melting point additive may be 10% or more with respect to the total weight of the fill material, and may have a melting point of about 20 to 50° C. The low melting point additive may be selected from the group consisting of chocolate base, lard, coconut oil and macrogol (polyethylene glycol) as well as a combination thereof. | 09-23-2010 |
20100266665 | Fenugreek Flour for Incorporating Into Food Products - A process for obtaining fenugreek flour from fenugreek seeds has been developed, and the flour incorporated into baked or other food products. The processed fenugreek flour from boiled seeds was easier to add into food products than whole seeds and did not compromise the food's taste or texture. This fenugreek flour can be included in everyday food items and will allow increased use in fenugreek to aid in the prevention of diabetes and obesity. Using this flour, a fenugreek bread formula was developed, and the bread was produced in a commercial bakery by incorporating fenugreek flour into a standard wheat bread formula. Eight diet controlled diabetic subjects were served wheat bread with about 5% fenugreek, and the consumption of the fenugreek bread was shown to reduce serum insulin indicating the bioactivity of the fenugreek remained in the bread. | 10-21-2010 |
20100278899 | EDIBLE FILM - An edible film to be ingested from an oral cavity of a living body to a body thereof is provided. The edible film is comprised of a laminated body consisting of a plurality of layers. The laminated body has surfaces and the plurality of layers include two surface layers forming of the surfaces of the laminated body. At least one of the two surface layers is disposed as an antiadhesive layer for preventing the edible film from adhering to an inside wall of the oral cavity by dissolving with water. This edible film is a film that it is difficult to adhere to the inside wall of the oral cavity, and even if it adheres to the inside wall, it is possible to easily peel off the edible film therefrom. | 11-04-2010 |
20100316692 | Product and method for reducing substance craving - A composition and method are provided that are effective for reduction or elimination of the craving foods and other substances for which a patient wishes to reduce consumption or intake. The composition is a paste made of a binder, and non-binder ingredients of mustard, pepper and salt, and optionally a sweetener. The composition of the invention is administered on the tongue as a paste. | 12-16-2010 |
20100330150 | Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs - The present invention is directed to pharmaceutical compositions comprising a plurality of taste-masked high-dose/low-dose drug-containing microparticles, dosage forms comprising such pharmaceutical compositions (such as an orally disintegrating tablet), and methods of making the pharmaceutical compositions and dosage forms of the present invention. Dosage forms comprising the pharmaceutical compositions of the present invention are improved homogeneous blends of high-dose and low-dose drugs which provide for more convenient and palatable administration of drug combinations, for example for treating pain, hyperglycemia, cardiovascular disease, and allergies. | 12-30-2010 |
20100330151 | Method of Promoting Gastrointestinal Health Using a Combination of a Probiotic Microorganism and Chocolate - The present invention is directed to a method of treating or maintaining protection from episodic gastrointestinal disturbances, by providing a composition comprising a probiotic microorganism and chocolate wherein said probiotic microorganism is selected from the group consisting of | 12-30-2010 |
20110014268 | FORMULATION FOR ORAL ADMINISTRATION - There is provided a formulation for oral administration ( | 01-20-2011 |
20110027342 | S-ADENOSYLMETHIONINE FORMULATIONS WITH ENHANCED BIOAVAILABILITY - The invention relates to compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and to methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. The enhanced bioavailability formulations may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia; as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease. | 02-03-2011 |
20110081400 | NUTRITIONAL COMPOSITION FOR BARIATRIC SURGERY PATIENTS - A nutritional composition particularly suitable for use by morbidly obese patients pre and post bariatric surgery comprises 20-60 wt % protein source, 15-55 wt % carbohydrate, 10-20 wt % soluble dietary fibres, less than 10 wt % fat and micronutrients. The micronutrients comprise
| 04-07-2011 |
20110091521 | Edible spoon for dissociating into consumable predetermined clumps in order to prevent dissociating into random granules that would make consumption more difficult - An edible spoon for dissociating into consumable predetermined clumps in order to prevent dissociating into random granules that would make consumption more difficult. The edible spoon includes a bowl and a handle. The bowl extends from the handle and contains weakened lines. The weakened lines in the bowl define the consumable predetermined clumps so as to allow the bowl to dissociate into the consumable predetermined clumps in order to prevent dissociating into the random granules that would make the consumption more difficult. | 04-21-2011 |
20110104237 | BONE STRENGTHENING FOOD SUPPLEMENT - Black beans B are coated with a mineral layer | 05-05-2011 |
20110111009 | METHODS AND FORMULATIONS FOR ENHANCING THE ABSORPTION AND DECREASING THE ABSORPTION VARIABILITY OF ORALLY ADMINISTERED DRUGS, VITAMINS AND NUTRIENTS - A method of preparing and composition of bioavailable hydrophobic, poorly water soluble drugs. It uses for example, lecithin, sterol, a calcium salt, and solvent; mixing to form liposomes and then the solvent driven off; the ratios used and physical form differ from others, and maximize performance. | 05-12-2011 |
20110150968 | DISSOLVABLE DIETARY SUPPLEMENT STRIP AND METHODS FOR USING THE SAME - A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip. | 06-23-2011 |
20110182969 | THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM - The invention relates to film products containing desired levels of active components and methods of their preparation. Desirably, the films disintegrate in water and may be formed by a controlled drying process, or other process that maintains the required uniformity of the film. Desirably, the films may be exposed to temperatures above that at which the active components typically degrade without concern for loss of the desired activity. | 07-28-2011 |
20110223234 | Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof - A palatable, edible soft chewable medication vehicle for delivery of a pharmaceutically acceptable active ingredient, such as a drug, to an animal or human subject. The edible soft chews contain only food grade or better inactive ingredients, and preferably do not contain ingredients of animal origin. Processes for manufacturing the edible soft chews do not require the use of heat or the addition of water during mixing of active and inactive ingredients, provide stable concentrations of the active ingredient, and produce chews of consistent weight and texture. | 09-15-2011 |
20110244018 | DECONTAMINANT EDIBLE PRODUCT, METHODS OF PRODUCTION AND USES THEREOF - The invention relates to an edible product containing a decontaminant. Particularly, the invention relates to an edible product, for instance, a food-like product, containing an effective amount of activated charcoal to mitigate, substantially reduce or cause the cessation of at least one adverse effect associated with the ingestion of a toxic substance. The invention also relates to methods for manufacturing such a decontaminant edible product and uses thereof. | 10-06-2011 |
20110250256 | Dissolvable Nano Web Porous Film and Method of Preparing the Same - A dissolvable nano web porous film has a network structure and a large specific surface area. The network structure is formed by stacking nano fibers that have a thickness of 10˜50,000 nm. The nano fibers are formed of a composition comprising nano fiber forming polymer, a gelling agent, a plasticizer, an optional active component and an optional additive. A method of preparing a dissolvable nano web film comprises producing a polymer melt or solution formed of a composition that comprises a nano fiber forming polymer, a gelling agent, a plasticizer, an optional active component and additives, spinning the melt or solution to form a nano web porous film having nano webs stacked in a network structure, drying the nano web porous film, and stabilizing the nano web porous film. The porous film has a 5˜5000 times higher specific surface area and a 2˜20 times faster dissolving time than a conventional film. The dissolvable nano web porous film has excellent dissolvability and solubility. | 10-13-2011 |
20110256207 | WHOLE GRAIN FLOUR AND PRODUCTS INCLUDING SAME - The present invention is a grain product. The grain product includes a first fraction including bran. The first fraction is milled to a first particle size of less than 500 micrometers. The grain product also includes a second fraction including germ. The second fraction is milled to a second particle size of less than 500 micrometers. The grain product is at least one of: a food product, a nutritional supplement, a dietary supplement, a fiber supplement, a digestive supplement, a functional food, and a medical food. | 10-20-2011 |
20110274741 | INGESTIBLE COMPOSITIONS AND PROCESSES OF PREPARATION - One or more of hydrolysed wheat flour, soluble dietary fibre, prebiotic dietary fibre, polydextrose and soluble corn fibre ate used as basic matrix-forming ingredients in an expanded food product. The matrix-forming ingredients are mixed together with water, plus a whey protein isolate or whey protein concentrate, to increase the protein content of the food. A dough is formed which is then formed into pieces which are temperature conditioned before being expanded under a vacuum caused by evaporation of moisture in the dough. All steps of the process of making the expanded food products, including any subsequent drying, is carried out at a temperature not exceeding 75° C., which advantageously allows mixing in of temperature sensitive ingredients, e.g. vitamins, pharmaceuticals, at the dough forming stage. The products have a honeycomb structure and there is no significant change in flavour or nutritional value of the ingredients caused by the process of manufacture. Advantageously, acrylamide formation is also avoided. | 11-10-2011 |
20110300204 | NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE - The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a large lipid globule size, having a volume weighted mode diameter above 1.0 μm and/or with a diameter of 2 to 12 μm in a amount of at least 45 volume % based on total lipid. The composition can be used to increase bone mineral content and/or bone mass density, to prevent osteoporosis and/or osteopenia and for the further prevention of obesity. | 12-08-2011 |
20120009239 | Prebiotic Formulations for use with Probiotics to Increase Probiotic Growth Rate and Activity - Naturally occurring lecithins and/or oleic acid stimulate the growth and lactic acid producing activity of | 01-12-2012 |
20120058172 | PLANT EXTRACTS FOR USE IN BRAIN MODULATION - Compounds obtainable from plants, e.g. of the genus | 03-08-2012 |
20120064143 | INHIBITION OF MAMMALIAN TARGET OF RAPAMYCIN - Disclosed are microcapsules that include an inhibitor of the mammalian target of rapamycin (mTOR) within the microcapsules, and pharmaceutical compositions and kits that include the microcapsules. Also disclosed are methods for treating or preventing an age-related disease, condition, or disorder in a subject that involve administering to a subject a pharmaceutically effective amount of microcapsules that includes an inhibitor of mTOR within the microcapsules. | 03-15-2012 |
20120076849 | PLANT COMPOSITION FOR THE TREATMENT OR PREVENTION OF VIRAL BLOOD-BORNE DISEASES SUCH AS DISEASES CAUSED BY THE HUMAN IMMUNODEFICIENCY VIRUS (HIV) OR HEPATITIS C - A composition based on plants for treating or preventing viral diseases of the blood, such as the diseases caused by the virus of human immunodeficiency (HIV) or hepatitis C. The composition comprises flower of sulfur, a plant containing catechin and a tannin agent, and a pharmaceutically acceptable carrier. The plant is selected from | 03-29-2012 |
20120107386 | COMPOSITION AND METHOD FOR INCORPORATING NUTRIENTS INTO CONDIMENTS AND USE THEREOF IN COOKED FOODS - A composition comprising a nutrient encapsulated in a coating and a condiment is disclosed. A method of manufacturing the composition is also disclosed. | 05-03-2012 |
20120121685 | BREAKFAST CEREALS CONTAINING PROBIOTIC MICRO ORGANISMS - The present invention relates to the field of nutrition. In particular, the present invention relates to a breakfast cereal composition comprising probiotic micro-organisms. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 05-17-2012 |
20120282317 | Medicated popsicle system - A system for providing medication in an edible frozen form consists of a popsicle mold, a popsicle holder with a core stick, handle and drip guard, and a liquid mixture containing sweeteners, edible colorants, and flavorings which is individually mixed with medication for each popsicle in order to add a custom flavoring to mask the taste of the medicine and encourage consumption by children. The system also includes a mixing implement and storage for the mixing implement incorporated into the popsicle mold, writable and erasable areas on the mold where information particularly relevant to the medicine type, dosage and administration schedule can be written and then changed as needed, an erasable writing implement, and storage for the writing implement incorporated into the popsicle mold. | 11-08-2012 |
20130064874 | METHOD FOR PRODUCING ORALLY ADMINISTRABLE EDIBLE AGENT OF AGGREGATED SUBSTANCE-CONTAINING LAMINATE FILM FORM AND ORALLY ADMINISTRABLE EDIBLE AGENT OF AGGREGATED SUBSTANCE-CONTAINING LAMINATE FILM FORM - In pressure bonding edible layers having irregular surfaces due to the presence of aggregated substance so that the irregular surfaces face each other, an edible layer substantially free of any aggregated substance is interposed therebetween. This allows an orally administrable edible agent of aggregated substance-containing laminate film form having a multilayer structure including laminated extremely thin layers to be produced. The multilayer structure by such a pressure bonding technique can satisfy quantitative accuracy required for pharmaceutical preparations, and prevents time constraint in a drying step or the like, thereby providing a producing method with high productivity. | 03-14-2013 |
20130142859 | COMPOSITIONS AND METHODS FOR THE SUSTAINED RELEASE OF BETA-ALANINE - Methods and compositions are provided for increasing the anaerobic working capacity of muscle and other tissues. Also provided are compositions formulated for the sustained release of free beta-alanine. Also provided is a dietary supplement formulated, for example, as a solid food product, an edible suspension, liquid or semi-liquid as described herein. | 06-06-2013 |
20130171230 | RECONSTITUTED NUT AND/OR CAROB INGREDIENT - The present invention describes a reconstituted food ingredient comprising a nut, a carob, a derivative thereof or their mixtures having a low fat content, or a low sugar content, or low fat and sugar content, characterized in that it is enriched with phenolic compounds, and/or sterols and tocopherols originating from nut or carob. The invention also describes a method for preparing said reconstituted food ingredient, as well as its use in the treatment and/or prevention of cardiovascular diseases, vascular diseases, neuronal diseases, neurodegenerative diseases, cancer, inflammatory processes, metabolic syndrome diseases, etc., by means of using this ingredient in the diet. The use of said ingredient in preparing a food composition and various food compositions for human or animal consumption is also described. | 07-04-2013 |
20130209540 | MULTI-LAYER NICOTINE-CONTAINING PHARMACEUTICAL COMPOSITION - The invention provides a multi-layered pharmaceutical composition comprising two or more formulations with varying properties. In some embodiments, the pharmaceutical compositions provide combinations of different organoleptic properties within the same product. In certain embodiment, these combinations allow for a modified release profile of active ingredients as the user enjoys the pharmaceutical composition. The invention further provides methods for making and using the pharmaceutical composition. | 08-15-2013 |
20130224279 | PROCESS FOR THE PREPARATION OF CALCIUM SALT SUSPENSIONS - The current invention is related to a novel process for the production of aqueous suspensions of micro and nanoparticles of calcium salts smaller than 10 μm particle size, along with a method to enrich nutritional, nutraceutical, and pharmaceutical beverages with calcium salts. In the process, an aqueous suspension of calcium salt is subjected to pressurization with critical, subcritical, or supercritical carbon dioxide to increase the solubility of the calcium salt, which has a particle size greater than 30 μm. The resulting solution is expanded through a nozzle to generate a calcium salt suspension of micro and nanoparticles that is imperceptible to sight and taste. | 08-29-2013 |
20140017293 | COMPOSITIONS AND METHODS FOR THE SUSTAINED RELEASE OF BETA-ALANINE - Methods and compositions are provided for increasing the anaerobic working capacity of muscle and other tissues. Also provided are compositions formulated for the sustained release of free beta-alanine. Also provided is a dietary supplement formulated, for example, as a solid food product, an edible suspension, liquid or semi-liquid as described herein. | 01-16-2014 |
20140023693 | PROTECTION OF MICROBIAL CELLS FROM ACIDIC DEGRADATION - A simple cellulose sulphate based microencapsulation technology has been applied to encapsulate bacterial or other microbial cells, which produce and release digestive enzymes and thereby provides an acid resistant shelter for these microbial cells. Surprisingly, the resulting spheres were found to provide sufficient protection for encapsulated cells from treatment with aqueous acidic solutions. Thereby the cellulose sulphate microencapsulated cells, such as probiotics are now enabled to survive passage, for example, through the stomach after consumption by a human or animal with a higher survival rate than those not within a microcapsule. After passing the stomach these cells are delivering products produced by them, e.g. enzymes or other nutrition factors. This technology therefore proves to be very useful in providing digestive or otherwise beneficial enzymes and/or of living microbial cells, into the lower gastrointestinal tract, where they could confer their health benefit to the host. | 01-23-2014 |
20140093554 | NUTRITIONAL COMPOSITIONS WITH LARGE LIPID GLOBULE SIZE - The present invention relates to a nutritional composition for infants and/or toddlers comprising a lipid component which has a large lipid globule size. The composition can be used to increase bone mineral content and/or bone mass density. | 04-03-2014 |
20140105958 | EDIBLE STICKER WITH NUTRIENT - An edible sticker including an edible paper, an edible ink, and an edible compound on at least a portion of the edible paper. The edible compound includes one selected from a nutrient, a supplement, a medicine, a mineral, a flavoring, a vitamin, and combinations thereof. A method of providing nutrients to a child using the edible sticker, a method of manufacturing the edible sticker, and a system for manufacturing the edible sticker have also been disclosed. | 04-17-2014 |
20140112971 | Edible Product - The present invention describes an orally administered edible product designed to provide a health benefit in a delivery formulation that will increase ease of use and thus lead to increased compliance and consumption to promote human health and wellness. | 04-24-2014 |
20140120150 | Dissolvable Strip for Treatment of Oral Thermal Burns - A consumable film adapted to adhere and to dissolve in the oral cavity that provides a local anesthetic and therapeutic agents for the treatment of oral burns or injuries. The film is designed to instantly release benzocaine, or other types of local anesthetic or therapeutic agent, upon adhesion to the affected areas of the mouth, and will continue to release sufficient quantities for pain relief and for healing over an extended period of time. | 05-01-2014 |
20140170203 | ENCLOSING MATERIALS IN NATURAL TRANSPORT SYSTEMS - A manufactured system for storage and delivery of an edible or potable substance is claimed. | 06-19-2014 |
20140271782 | METHOD FOR PREPARING NANOLIPIDS WITH ENCAPSULATED ALCOHOL - A method for preparing ethanol-containing nanolipid particles, which can be used in food products, frozen desserts, or beverages. The method comprises nanolipidic vehicles in which ethanol-containing substances are encapsulated, said ethanol-containing nanolipidic vehicles can be combined with food products, desserts or beverage ingredients including those that are subsequently frozen, The food product, dessert or beverage can remain in a frozen state during consumption by an individual. A composition comprising ethanol-containing nanolipid particles, which can be used in food products, frozen desserts, or beverages. | 09-18-2014 |
20150017223 | EDIBLE COATING COMPOSITION AND USES THEREOF - Described herein is an edible coating for food products in which the coatings comprises a polysaccharide cross-linked with a cross-linking agent solution. Also described herein are methods for coating food products and forming clusters of food products. The use of the edible coating for extending the shelf-life of food products is also described. | 01-15-2015 |
20150037388 | EDIBLE SLOW DISSOLVING FILM FOR TREATING ORAL ULCERATIONS - The invention relates, in one aspect, to a mucoadhesive edible slow dissolving film comprising a salt of alginic acid, an edible cellulose derivative, an edible protein, and edible polymer delaying the dissolution in a physiological fluid of the edible film selected from polyvinylpyrrolidone, a carboxyvinyl polymer and mixtures thereof, in an amount effective to delay the dissolution time of the film in a biological fluid. The edible film is suitable for cicatrizing oral ulcerations or lesions or for forming a layer on oral mucosae or gingiva affected by ulcerations or lesions for protecting against mechanical abrasions, infections or caustic agents. | 02-05-2015 |
20150037389 | Edible Product Comprising Reconstituted Plant Material - The present invention relates to an edible product, which comprises a fibrous plant product and a plant extract applied thereto. Further, the invention relates to a corresponding method for producing said edible product and its use in at least one of food, food supplement, medicinal, cosmetic, well-being, nutraceutical or phytotherapeutical applications. The plants used may be all plants comprising one or more substances of interest for an edible product. | 02-05-2015 |
20150079149 | DISSOLVABLE DIETARY SUPPLEMENT STRIP AND METHODS FOR USING THE SAME - A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip. | 03-19-2015 |
20150104493 | Dissolvable Strip for Treatment of Oral Thermal Burns - A consumable film adapted to adhere and to dissolve in the oral cavity that provides a local anesthetic and therapeutic agents for the treatment of oral burns or injuries. The film is designed to instantly release benzocaine, or other types of local anesthetic or therapeutic agent, upon adhesion to the affected areas of the mouth, and will continue to release sufficient quantities for pain relief and for healing over an extended period of time. | 04-16-2015 |
20150132359 | COMPOSITIONS AND METHODS FOR PRODUCING STABLE NEGATIVE OXIDATION REDUCTION POTENTIAL IN CONSUMABLE MATERIALS - Compositions of reducing agents and carriers for producing a stable negative oxidation reduction potential in consumable materials are disclosed and claimed. Compositions of the invention find use in enhancing the hydration and anti-oxidant value of consumable materials such as foods, beverages and cosmetics, for example. Compositions of the invention also find use in water treatment, agricultural and scientific research applications. Methods for using and making the compositions are also within the scope of the invention. | 05-14-2015 |
20150342226 | METHOD FOR PREPARING NANOLIPIDS WITH ENCAPSULATED ALCOHOL - A method for preparing ethanol-containing nanolipid particles, which can be used in food products, frozen desserts, or beverages. The method comprises nanolipidic vehicles in which ethanol-containing substances are encapsulated, said ethanol-containing nanolipidic vehicles can be combined with food products, desserts or beverage ingredients including those that are subsequently frozen. The food product, dessert or beverage can remain in a frozen state during consumption by an individual. A composition comprising ethanol-containing nanolipid particles, which can be used in food products, frozen desserts, or beverages. | 12-03-2015 |
20150359739 | EDIBLE FILM-STRIPS FOR IMMEDIATE RELEASE OF ACTIVE INGREDIENTS - The present invention is directed to an edible film that contains two or more segmented portions and comprises an active ingredient that is distributed on a segmented portion or portions which comprise less than 50% of the cross sectional surface area of a major face of said film. The present invention also relates to methods of treatment for the treatment of various conditions and for taste-masking of pharmaceutical ingredients. | 12-17-2015 |
20150366241 | COMPOSITIONS OF PARTICULATE COFORMULATION - Embodiments of the invention provide a composition of a particulate coformulation which includes particles containing an active substance and an additive, wherein each particle contains a relative additive concentration increasing radially outwards from a particle center to a particle surface along a finite gradient. In one example, the particle surface is an additive-rich surface without a distinct physical boundary between the particle center and the particle surface. The relative additive concentration may have a continuous rate of change across the finite gradient. In some examples, an active substance:additive ratio of the particle surface is sufficiently low to form a protective surface layer around the active substance. Generally, the particle surface is free of the active substance. | 12-24-2015 |
20160015764 | SIRAITIAE FRUCTUS PRODUCT AND PREPARATION METHOD THEREOF - This invention relates to a Siraitiae fructus product and a method for preparing the same. The product uses a Siraitiae fructus seed as a carrier, and Siraitiae fructus flesh is coated on the carrier. The flesh may the original flesh tissue, or flesh pulp prepared through a physical method. The product is convenient for eating, and has a distinct flavor and a high amount of active ingredients. The preparation method is simple and practical, and significantly reduces energy consumption. | 01-21-2016 |
20160022782 | INSULIN-CONTAINING INFANT FORMULA - The present invention provides compositions methods and kits for improved infant formula, particularly to insulin-supplements and formulae comprising same that mimic the diurnal rhythm and/or the postpartum variation of insulin in human milk. | 01-28-2016 |
20160030335 | METHODS FOR MODULATING DISSOLUTION, BIOAVAILABILITY, BIOEQUIVALENCE AND DRUG DELIVERY PROFILE OF THIN FILM DRUG DELIVERY SYSTEMS, CONTROLLED-RELEASE THIN FILM DOSAGE FORMATS, AND METHODS FOR THEIR MANUFACTURE AND USE - Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use are disclosed. | 02-04-2016 |
20160030401 | USE OF MTOR INHIBITORS FOR PREVENTION OF INTESTINAL POLYP GROWTH AND CANCER - Disclosed are methods and compositions for the treatment or prevention of intestinal polyps or prevention of cancer in a patient who has been identified as being at risk for developing intestinal polyps or intestinal cancer. The disclosed methods and compositions include rapamycin, a rapamycin analog, or another such inhibitor of the target of rapamycin (TOR). | 02-04-2016 |
20160030470 | LIQUIDS RICH IN NOBLE GAS AND METHODS OF THEIR PREPARATION AND USE - Provided herein is a novel composition for oral administration and delivery of Noble gas, such as xenon or argon. Methods of treating and preventing neuronal or cardiovascular damage with such compositions are also provided. The present invention relates generally to the fields of molecular biology, medicine and nutraceuticals. More particularly, it concerns methods for oral delivery of inert gas compositions, such as Xenon or Argon, for the treatment and prevention of disease. | 02-04-2016 |
20160038436 | LUTEIN COMPOSITION SUITABLE FOR INFANT FOOD FORMULATIONS - The present invention is related to a powderous composition which comprises lutein and which is used in infant food formulations or premixes for infant food formulations. | 02-11-2016 |
20160058711 | ORAL FILM-FORM BASE AND PREPARATION - The present invention aims to provide an oral film-form base and an oral film-form preparation which have a rapid dissolution profile in the mouth and sufficient film strength, give a good tactile impression when handled with fingers and favorable texture and taste in the mouth, and are administrable to those who have limitation in carbohydrate intake. The present invention relates to an oral film-form base including an edible polymer soluble in water and an organic solvent having a solubility parameter of 9.7 or higher, and particles of at least one compound selected from the group consisting of amino acid, dipeptide, and nucleotide, the particles of at least one compound selected from the group consisting of amino acid, dipeptide, and nucleotide being dispersed in the state of particles in the oral film-form base. | 03-03-2016 |
20160113987 | NUTRITIONAL SUPPLEMENTS - Compositions are provided for preparing low dosage supplements in the form of a confectionery which are easy to swallow and have a desirable taste. The resulting compositions are suitable for delivering all natural active ingredients to aid in alleviating a particular disease or promote overall well-being. Methods of forming the confectionery are also provided herein. | 04-28-2016 |
20160151501 | POWDER MIXTURES FOR ANTIBIOTIC DRY SYRUP FORMULATIONS | 06-02-2016 |
20160157513 | FRUIT SNACKS FORTIFIED WITH POLYUNSATURATED FATTY ACIDS - According to some embodiments, a method comprises mixing a plurality of first ingredients into a slurry, cooking the slurry, and cooling the slurry to a temperature less than approximately 100° C. A polyunsaturated fatty acid (PUFA) is added to the cooled slurry, and the PUFA-fortified slurry is deposited into metal mold trays that have been coated with wax. The metal mold trays are cooled until the slurry sets into fruit snacks. | 06-09-2016 |
20160192689 | ENCAPSULATED FUNCTIONAL FOOD COMPOSITIONS | 07-07-2016 |
20160193266 | METHOD AND APPARATUS FOR SMOKE-INFUSING PROTEINACEOUS FOODS AND SMOKED-INFUSED SUCH PROTEINACEOUS FOOD PRODUCT SO-OBTAINED | 07-07-2016 |
20180021310 | MEBENDAZOLE POLYMORPH FOR TREATEMENT AND PREVENTION OF TUMORS | 01-25-2018 |
20180021388 | AVIAN FOLLISTATIN PRODUCT | 01-25-2018 |
20190142051 | AN EDIBLE COMPOSITION FOR REDUCING THE DIGESTION OR ABSORPTION OF THE HARMFUL/TOXIC SUBSTANCE | 05-16-2019 |